Joel Okoli

584 total citations
24 papers, 431 citations indexed

About

Joel Okoli is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Joel Okoli has authored 24 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Joel Okoli's work include Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (5 papers) and Global Cancer Incidence and Screening (4 papers). Joel Okoli is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (5 papers) and Global Cancer Incidence and Screening (4 papers). Joel Okoli collaborates with scholars based in United States, Nigeria and Canada. Joel Okoli's co-authors include Harvey L. Bumpers, Monica Rizzo, Sheryl G. A. Gabram, Mary Jo Lund, Otis W. Brawley, Sheryl Gabram‐Mendola, Gabriela Oprea‐Ilies, Gabriela Oprea, Eboneé N. Butler and Monica Rizzo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncogene.

In The Last Decade

Joel Okoli

24 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Okoli United States 12 213 134 110 81 77 24 431
Christina A. Dilaveri United States 8 179 0.8× 205 1.5× 116 1.1× 71 0.9× 65 0.8× 17 409
J Stefoski Mikeljevic United Kingdom 8 252 1.2× 155 1.2× 70 0.6× 119 1.5× 25 0.3× 10 457
Anna I. Holbrook United States 14 206 1.0× 246 1.8× 232 2.1× 77 1.0× 22 0.3× 25 659
Tsutomu Kouno Japan 12 241 1.1× 108 0.8× 80 0.7× 110 1.4× 63 0.8× 31 432
Offiong F. Ikpatt United States 10 176 0.8× 91 0.7× 101 0.9× 21 0.3× 45 0.6× 27 367
Fiona Nussey United Kingdom 11 173 0.8× 71 0.5× 37 0.3× 47 0.6× 87 1.1× 21 380
Julie K. Jang United States 11 220 1.0× 87 0.6× 70 0.6× 116 1.4× 100 1.3× 32 503
Chizuko Kanbayashi Japan 12 355 1.7× 179 1.3× 76 0.7× 87 1.1× 114 1.5× 36 593
Elias Nasser Australia 9 274 1.3× 296 2.2× 137 1.2× 136 1.7× 54 0.7× 23 542
Rachel Würstlein Germany 9 260 1.2× 138 1.0× 36 0.3× 31 0.4× 58 0.8× 58 465

Countries citing papers authored by Joel Okoli

Since Specialization
Citations

This map shows the geographic impact of Joel Okoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Okoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Okoli more than expected).

Fields of papers citing papers by Joel Okoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Okoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Okoli. The network helps show where Joel Okoli may publish in the future.

Co-authorship network of co-authors of Joel Okoli

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Okoli. A scholar is included among the top collaborators of Joel Okoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Okoli. Joel Okoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowaiye, Adekunle Babajide, et al.. (2025). Advancing predictive modeling in computational chemistry through quantum chemistry, molecular mechanics, and machine learning. Discover Chemistry.. 2(1). 1 indexed citations
2.
Ibeanu, Gordon C., et al.. (2024). Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery. ImmunoTargets and Therapy. Volume 13. 749–774. 6 indexed citations
3.
Okoli, Joel, et al.. (2021). Validation of Use of Flipped Classroom for Surgery Core Clerkships. Journal of surgical education. 79(3). 668–675. 3 indexed citations
4.
Weiler, Michael, et al.. (2020). An infrared 3D scanning device as a novel limb volume measurement tool in breast cancer patients. World Journal of Surgical Oncology. 18(1). 278–278. 12 indexed citations
5.
Hansen, Nora, et al.. (2019). A Provocative Molecular Link between Mammographic Density and BRCA1-loss associated TNBC. PubMed Central. 1 indexed citations
6.
Binkley, Jill, et al.. (2018). Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery. Clinical Breast Cancer. 18(6). e1261–e1267. 19 indexed citations
7.
Okoli, Joel, et al.. (2017). A novel Ubc9 -dependent pathway regulates SIRT1- ER-α Axis and BRCA1- associated TNBC lung metastasis. Integrative Molecular Medicine. 4(4). 5 indexed citations
8.
Lai, Lisa A., Jill Binkley, Veronica Jones, et al.. (2016). Implementing the Prospective Surveillance Model (PSM) of Rehabilitation for Breast Cancer Patients with 1-Year Postoperative Follow-up, a Prospective, Observational Study. Annals of Surgical Oncology. 23(10). 3379–3384. 17 indexed citations
9.
Desai, Arpita, Jinhua Xu, Kartik Aysola, et al.. (2015). Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites. PubMed. 1(1). 7 indexed citations
10.
Bumpers, Harvey L., et al.. (2015). Phyllodes tumors in African American women. The American Journal of Surgery. 210(1). 74–79. 15 indexed citations
11.
Jones, Veronica, Jared H. Linebarger, Sebastian D. Perez, et al.. (2015). Excising Additional Margins at Initial Breast-Conserving Surgery (BCS) Reduces the Need for Re-excision in a Predominantly African American Population: A Report of a Randomized Prospective Study in a Public Hospital. Annals of Surgical Oncology. 23(2). 456–464. 19 indexed citations
12.
Oprea, Gabriela, Joel Okoli, Monica Rizzo, et al.. (2012). Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast: A Series of 24 Patients. The Breast Journal. 18(3). 242–247. 70 indexed citations
13.
Lund, Mary Jo, Monica Rizzo, Harvey L. Bumpers, et al.. (2010). Using National Quality Forum Breast Cancer Indicators to Measure Quality of Care for Patients in an AVON Comprehensive Breast Center. The Breast Journal. 16(3). 240–244. 10 indexed citations
14.
Rizzo, Monica, Harvey L. Bumpers, Joel Okoli, et al.. (2010). Improving on National Quality Indicators of Breast Cancer Care in a Large Public Hospital as a Means to Decrease Disparities for African American Women. Annals of Surgical Oncology. 18(1). 34–39. 10 indexed citations
15.
Lund, Mary Jo, Eboneé N. Butler, Harvey L. Bumpers, et al.. (2008). High prevalence of triple‐negative tumors in an urban cancer center. Cancer. 113(3). 608–615. 75 indexed citations
16.
Gabram, Sheryl G. A., Mary Jo Lund, Harvey L. Bumpers, et al.. (2008). Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African‐American population. Cancer. 113(3). 602–607. 62 indexed citations
17.
Okoli, Joel, et al.. (2008). Abnormal Mammogram Follow-Up: Do Community Lay Health Advocates Make a Difference?. Health Promotion Practice. 9(2). 140–148. 16 indexed citations
18.
Shao, Ning, et al.. (2007). BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers. Oncogene. 26(41). 6031–6037. 34 indexed citations
19.
Bumpers, Harvey L., Ming‐Bo Huang, Michael D. Powell, et al.. (2005). Effects of HIV-1 Nef, a cytotoxic viral protein, on the growth of primary colorectal cancer. Cancer Biology & Therapy. 4(1). 72–76. 15 indexed citations
20.
Aikhionbare, Felix, Masood Khan, Delicia Carey, Joel Okoli, & Rodney C.P. Go. (2004). Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression?. Molecular Cancer. 3(1). 30–30. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina A. Dilaveri Breakdown of academic impact, for papers by J Stefoski Mikeljevic Breakdown of academic impact, for papers by Anna I. Holbrook Breakdown of academic impact, for papers by Tsutomu Kouno Breakdown of academic impact, for papers by Offiong F. Ikpatt Breakdown of academic impact, for papers by Fiona Nussey Breakdown of academic impact, for papers by Julie K. Jang Breakdown of academic impact, for papers by Chizuko Kanbayashi Breakdown of academic impact, for papers by Elias Nasser Breakdown of academic impact, for papers by Rachel Würstlein
Rankless by CCL
2026